References
- Agarwala SS, Hellstrand K, Gehlsen K, Naredi P. 2004. Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis. Cancer Immunology, Immunotherapy 53:840–841.
- Barcellos-Hoff MH, Park C, Wright EG. 2005. Radiation and the microenvironment tumorigenesis and therapy. Nature 5:867–874.
- Betzen SM, Overgaard J. 1997. Clinical manifestations of normal tissue damage. In: Steel GG, editor. Basic clinical radiobiology. 2nd ed. New York: Oxford University Press, Inc. pp 87–97.
- Ching TL, Haenen GR, Bast A. 1993. Cimetidine and other H2 receptor antagonists as powerful hydroxyl radical scavengers. Chemico-biological Interactions 86:119–127.
- Duhamel G, Muratore R, Bryon PA, Horschowski N. 1976. Les lesions histologiques de dans l'aplasie medullaires. Resultats d'un protocole commun portant 261 biopses. Nouvelle Revue Française d'Hématologie 21681–21686.
- Dziegielewski J, Baulch JE, Goetz W, Coleman MC, Spitz DR, Murley JS, Grdina DJ, Morgan WF. 2008. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability. Free Radical Biology and Medicine 45:1674–1681.
- Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. 1991. Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics 21:109–122.
- Endo Y, Nakamura M, Nitta Y, Kumagai K. 1995. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. British Journal of Pharmacology 114:187–193.
- Galmarini CM. 2004. Histamine dihydrochloride (subcutaneous) Maxim. Current Opinion in Investigational Drugs 5:1298–1310.
- Grdina DJ, Murley JS, Kataoka Y. 2002. Radioprotectans: Current status and new directions. Oncology 63:2–10.
- Hall EJ, Giaccia AJ. 2006a. Clinical response of normal tissues. In: Hall EJ, Giaccia AJ, editors. Radiobiology for radiobiologists. 6th ed. Philadelphia: Lippincott Williams and Wilkins. pp 327–348.
- Hall EJ, Giaccia AJ. 2006b. Radioprotectors. In: Hall EJ, Giaccia AJ, editors. Radiobiology for radiobiologists. 6th ed. Philadelphia: Lippincott Williams and Wilkins. pp 129–134.
- Horvath Z, Pallinger E, Horvath G, Jelinek I, Falus A, Buzas EI. 2006. Histamine H1 and H2 receptors but not H4 receptors are upregulated during bone marrow regeneration. Cellular Immunology 244:110–115.
- Kelman Z. 1997. PCNA: Structure, functions and interactions. Oncogene 14:629–640.
- Liu C, Ma XJ, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW. 2001. Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Molecular Pharmacology 59:420–426.
- Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, Sanchez-Jimenez F, Bergoc R, Rivera E. 2006. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biology and Therapy 5:1462–1471.
- Medina V, Croci M, Mohamad N, Massari N, Garbarino G, Cricco G, Núñez M, Martín G, Crescenti E, Bergoc R, Rivera E. 2007. Mechanisms underlying the radioprotective effect of histamine on small intestine. International Journal of Radiation Biology 83:653–663.
- Mitchell MS. 2003. Immunotherapy as part of combinations for the treatment of cancer. International Immunopharmacology 3:1051–1059.
- Mozdarani H. 2003. Radioprotective properties of histamine H2 receptor antagonists: Present and future prospect. Journal of Radiation Research 44:145–149.
- Nieto LH, Rozman C. 1980. Biopsia medular en la clínica hematológica. Barcelona: Salvat SA.
- Pós Z, Hegyesi H, Rivera ES. 2004. Histamine and cell proliferation. In: Falus A, editor. Histamine: Biology and medical aspects, Budapest: SpringMed Publishing. pp 199–217.
- Prasad KN. Radiation syndromes and their modifications. 1995. In: Prasad KN, editor. Handbook of radiobiology. 2nd ed. Florida: CRC Press, Inc. pp 123–152.
- Romero AI, Thoren FB, Aurelius J, Askarieh G, Brune M, Hellstrand K. 2009. Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML. Scandinavian Journal of Immunology 70:194–205.
- Schneider E, Dy M. 2004. Histamine and hematopoiesis. In: Falus A, editor. Histamine: Biology and medical aspects. Budapest: SpringMed Publishing. pp 227–239.
- Steel GG. 1997. Introduction: The significance of radiobiology for radiotherapy. In: Steel GG, editor. Basic clinical radiobiology. 2nd ed. New York: Oxford University Press, Inc. pp 1–7.
- Weiss JF, Landauer MR. 2000. Radioprotection by antioxidants. Annals of the New York Academy of Sciences 899:44–60.